Skip to main content

Advertisement

Log in

Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Epidemiology and clinical outcomes of human cytomegalovirus (HCMV) infection are known to vary between countries and are associated with socio-economic background. So far, few data are available from developing countries, where the overall burden of infectious diseases is frequently higher. Therefore, we analyzed the seroprevalence in a population of 3,740 individuals selected randomly from eastern China, aiming to determine the seroprevalence of and risk factors for HCMV infection. The overall seroprevalence was 48.07%, higher in the socioeconomically developing inland districts than in the developed forelands. The seroprevalence in females (54.60%) was significantly higher than that in males (41.58%) (< 0.001). As for profession, peasants (61.54%) and doctors (68.48%) had a higher seropositive rate than members of other professions (< 0.0001). A significant association between seroprevalence and increasing age was identified (P < 0.05). Our study might help to identify appropriate populations on which to focus for future HCMV vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ahlfors K, Ivarsson SA, Harris S (1999) Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 31:443–457

    Article  PubMed  CAS  Google Scholar 

  2. Boeckh M, Fries B, Nichols WG (2004) Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation. Pediatr Transpl 8:19–27

    Article  Google Scholar 

  3. Chunying L, Chunlan L, Dongwe Y (2000) Study on human cytomegalovirus (HCMV) infection in the blood donor. Virol Sin 15:111–115

    Google Scholar 

  4. Colugnati FA, Staras SA, Dollard SC, Cannon MJ (2007) Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 7:71

    Article  PubMed  Google Scholar 

  5. Enright AM, Prober CG (2004) Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus. Pediatr Clin N Am 51:889–908

    Article  Google Scholar 

  6. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM (2002) Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 57:245–256

    Article  PubMed  Google Scholar 

  7. Guojun W, Shuzheng C, Liyu C, Menghui Y, Gan D (2001) Study on molecular epidemiology of HCMV infection in mothers and their newborns in Changsha. Bull Hunan Med Univ 26:23–25

    Google Scholar 

  8. Landolfo S, Gariglio M, Gribaudo G, Lembo D (2003) The human cytomegalovirus. Pharmacol Ther 98:269–297

    Article  PubMed  CAS  Google Scholar 

  9. Liangzhen W, Shengmei W, Sheng-min L, Zhixin W, Wangjiang Z, Xiaohu Q (1996) The epidemiological study on human cytomegalovirus infection of pregnant women and the Mater-nal-Fetal transmission in three Chinese metropolis. Chin J Obstet Gynecol 31:714–717

    Google Scholar 

  10. Pass RF (2001) Cytomegalovirus. Fields virology, 4th edn. Lippincott Williams & Wilkins, Boston, pp 2675–2705

    Google Scholar 

  11. Pereyra F, Rubin RH (2004) Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis 17:357–361

    Article  PubMed  CAS  Google Scholar 

  12. Schleiss MR, Heineman TC (2005) Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev Vaccines 4:381–406

    Article  PubMed  CAS  Google Scholar 

  13. Stagno S (1990) Cytomegalovirus. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 4th edn. WB Saunders, Philadelphia, pp 240–281

    Google Scholar 

  14. Stagno S, Gretchen AC (1990) Changes in the epidemiology of cytomegalovirus. Adv Exp Med Biol 278:93–104

    PubMed  CAS  Google Scholar 

  15. Yibing P, Limin Z, Ming L, Tao H, Ning P, Zhen Z (2002) Monitor human cytomegalovirus active infection by two quantitatively detect methods. Chin J Lab Med 25:220–222

    Google Scholar 

  16. Yunzhen G, Xin C, Yunwen H (1998) Study on HCMV antibodies of pregnant women. Acta Universitatis Medicinalis Anhui 23:96

    Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Fengqiang Wang (New York University School of Medicine) and Chengyun Zheng (CMM of Karolinska Institutet) for their critical review and valuable contributions in the preparation of this manuscript. This study was partially supported by grants from the National Natural Science Foundation (30600680) and the Shandong Technological Development Project (2005BS03022).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daoxin Ma.

Additional information

This study was partially supported by grants from the National Natural Science Foundation (30600680) and the Shandong Technological Development Project (2005BS03022).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, P., Ma, D., Xue, F. et al. Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population. Arch Virol 154, 561–564 (2009). https://doi.org/10.1007/s00705-009-0339-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-009-0339-3

Keywords

Navigation